Mechanisms of MHC class I - Restricted antigen processing

被引:797
作者
Pamer, E [1 ]
Cresswell, P
机构
[1] Yale Univ, Sch Med, Howard Hughes Med Inst, Dept Internal Med, New Haven, CT 06510 USA
[2] Yale Univ, Sch Med, Howard Hughes Med Inst, Immunobiol Sect, New Haven, CT 06510 USA
关键词
HLA; proteasome; antigen processing; chaperone;
D O I
10.1146/annurev.immunol.16.1.323
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Classical class I molecules assemble in the endoplasmic reticulum (ER) with peptides mostly generated from cytosolic proteins by the proteasome. The activity of the proteasome can be modulated by a variety of accessory protein complexes. A subset of the proteasome beta-subunits (LMP2, LMP7, and MECL-1) and one of the accessory complexes, PA28, are upregulated by gamma-interferon and affect the generation of peptides to promote more efficient antigen recognition. The peptides are translocated into the ER by the transporter associated with antigen processing (TAP). A transient complex containing a class I heavy chain-beta(2) microglobulin (beta(2)m) dimer is assembled onto the TAP molecule by successive interactions with the ER chaperones calnexin and calreticulin and a specialized molecule, tapasin. Peptide binding releases the class I-beta(2)m dimer for transport to the cell surface, while lack of binding results in proteasome-mediated degradation. The products of certain nonclassical MHC-linked class I genes bind peptides in a similar way. A homologous set of beta(2)m-associated membrane glycoproteins, the CD1 molecules, appears to bind lipid-based ligands within the endocytic pathway.
引用
收藏
页码:323 / 358
页数:36
相关论文
共 222 条
  • [1] AHN JY, 1995, FEBS LETT, V366, P37, DOI 10.1016/0014-5793(95)00492-R
  • [2] The ER-luminal domain of the HCMV glycoprotein US6 inhibits peptide translocation by TAP
    Ahn, K
    Gruhler, A
    Galocha, B
    Jones, TR
    Wiertz, EJHJ
    Ploegh, HL
    Peterson, PA
    Yang, Y
    Fruh, K
    [J]. IMMUNITY, 1997, 6 (05) : 613 - 621
  • [3] Human cytomegalovirus inhibits antigen presentation by a sequential multistep process
    Ahn, KS
    Angulo, A
    Ghazal, P
    Peterson, PA
    Yang, Y
    Fruh, K
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1996, 93 (20) : 10990 - 10995
  • [4] IDENTIFICATION OF A TAP-DEPENDENT LEADER PEPTIDE RECOGNIZED BY ALLOREACTIVE T-CELLS SPECIFIC FOR A CLASS IB ANTIGEN
    ALDRICH, CJ
    DECLOUX, A
    WOODS, AS
    COTTER, RJ
    SOLOSKI, MJ
    FORMAN, J
    [J]. CELL, 1994, 79 (04) : 649 - 658
  • [5] ENDOGENOUSLY SYNTHESIZED PEPTIDE WITH AN ENDOPLASMIC-RETICULUM SIGNAL SEQUENCE SENSITIZES ANTIGEN PROCESSING MUTANT-CELLS TO CLASS-I-RESTRICTED CELL-MEDIATED LYSIS
    ANDERSON, K
    CRESSWELL, P
    GAMMON, M
    HERMES, J
    WILLIAMSON, A
    ZWEERINK, H
    [J]. JOURNAL OF EXPERIMENTAL MEDICINE, 1991, 174 (02) : 489 - 492
  • [6] ANDERSON KS, 1993, J IMMUNOL, V151, P3407
  • [7] CHARACTERISTICS OF PEPTIDE AND MAJOR HISTOCOMPATIBILITY COMPLEX CLASS-I BETA(2)-MICROGLOBULIN BINDING TO THE TRANSPORTERS ASSOCIATED WITH ANTIGEN-PROCESSING (TAP1 AND TAP2)
    ANDROLEWICZ, MJ
    ORTMANN, B
    VANENDERT, PM
    SPIES, T
    CRESSWELL, P
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1994, 91 (26) : 12716 - 12720
  • [8] HUMAN TRANSPORTERS ASSOCIATED WITH ANTIGEN-PROCESSING POSSESS A PROMISCUOUS PEPTIDE-BINDING SITE
    ANDROLEWICZ, MJ
    CRESSWELL, P
    [J]. IMMUNITY, 1994, 1 (01) : 7 - 14
  • [9] EVIDENCE THAT TRANSPORTERS ASSOCIATED WITH ANTIGEN-PROCESSING TRANSLOCATE A MAJOR HISTOCOMPATIBILITY COMPLEX CLASS-I-BINDING PEPTIDE INTO THE ENDOPLASMIC-RETICULUM IN AN ATP-DEPENDENT MANNER
    ANDROLEWICZ, MJ
    ANDERSON, KS
    CRESSWELL, P
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1993, 90 (19) : 9130 - 9134
  • [10] CROSS-PRIMING OF MINOR HISTOCOMPATIBILITY ANTIGEN-SPECIFIC CYTOTOXIC T-CELLS UPON IMMUNIZATION WITH THE HEAT-SHOCK PROTEIN GP96
    ARNOLD, D
    FAATH, S
    RAMMENSEE, HG
    SCHILD, H
    [J]. JOURNAL OF EXPERIMENTAL MEDICINE, 1995, 182 (03) : 885 - 889